The proposal would see the HHS set price targets other countries pay for certain medicines, kicking off a round of ...

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

The biotech has quickly turned a cell therapy approval into one of the more lucrative recent sales for a priority review ...